about
Antimitotic drugs in the treatment of cancerChemotherapy and its evolving role in the management of advanced prostate cancerInteractive domains in the molecular chaperone human alphaB crystallin modulate microtubule assembly and disassemblyA novel synthetic microtubule inhibitor, MPT0B214 exhibits antitumor activity in human tumor cells through mitochondria-dependent intrinsic pathwayCharacterization, chemical optimization and anti-tumour activity of a tubulin poison identified by a p53-based phenotypic screenSynthesis and antitumor activity of 1,5-disubstituted 1,2,4-triazoles as cis-restricted combretastatin analogues.Antitumor Activity of IMC-038525, a Novel Oral Tubulin Polymerization Inhibitor.Synthesis and biological evaluation of 2-(3',4',5'-trimethoxybenzoyl)-3-aryl/arylaminobenzo[b]thiophene derivatives as a novel class of antiproliferative agents.Proteomic profiling of rabbit embryonic stem cells derived from parthenotes and fertilized embryos.Synthesis of novel antimitotic agents based on 2-amino-3-aroyl-5-(hetero)arylethynyl thiophene derivativesPhase I dose-finding study of cabazitaxel administered weekly in patients with advanced solid tumoursDesign, synthesis, biological evaluation, and structure-activity relationships of substituted phenyl 4-(2-oxoimidazolidin-1-yl)benzenesulfonates as new tubulin inhibitors mimicking combretastatin A-4.Intravenous therapies for castration-resistant prostate cancer: toxicities and adverse events.IPP51, a chalcone acting as a microtubule inhibitor with in vivo antitumor activity against bladder carcinoma.Evolving standards in the treatment of docetaxel-refractory castration-resistant prostate cancerManagement of metastatic castration-resistant prostate cancerAntiangiogenic effects of noscapine enhance radioresponse for GL261 tumors.Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-6-substituted-4,5,6,7-tetrahydrothieno[2,3-c]pyridine derivatives as antimitotic agents and inhibitors of tubulin polymerizationMulti-targeted therapy by curcumin: how spicy is it?Microtubule stabilising agents for cancer chemotherapy.Emerging novel therapies in the treatment of castrate-resistant prostate cancer.Progression of metastatic castrate-resistant prostate cancer: impact of therapeutic intervention in the post-docetaxel space.New therapies for castrate-resistant prostate cancer.Cabazitaxel: a novel microtubule inhibitor.The changing therapeutic landscape of castration-resistant prostate cancer.Castration-resistant prostate cancer: many treatments, many options, many challenges ahead.Emerging and second line therapies for the management of metastatic castration-resistant prostate cancer: the Australian perspective.Castration-resistant metastatic prostate cancer: current status and treatment possibilities.Urologists and oncologists: adapting to a new treatment paradigm in castration-resistant prostate cancer (CRPC).Castrate-resistant prostate cancer: postdocetaxel managementSafety and efficacy of cabazitaxel in the docetaxel-treated patients with hormone-refractory prostate cancer.The Emerging Role of Extracellular Vesicle-Mediated Drug Resistance in Cancers: Implications in Advanced Prostate CancerCabazitaxel for the treatment of castration-resistant prostate cancer.TROPIC: Phase III trial of cabazitaxel for the treatment of metastatic castration-resistant prostate cancer.Lead identification of conformationally restricted benzoxepin type combretastatin analogs: synthesis, antiproliferative activity, and tubulin effects.Quick and simple detection technique to assess the binding of antimicrotubule agents to the colchicine-binding site.Exposure-response relationship of the synthetic epothilone sagopilone in a peripheral neurotoxicity rat model.Desacetylvinblastine Monohydrazide Disrupts Tumor Vessels by Promoting VE-cadherin Internalization.PSA response to cabazitaxel is associated with improved progression-free survival in metastatic castration-resistant prostate cancer: the non-interventional QoLiTime study.Disruption of tubulin polymerization and cell proliferation by 1-naphthylarsonic acid.
P2860
Q26777317-41B6E2BD-3779-4BCF-9E83-0A6E1EB7A745Q27008883-2CDD4EBA-9A86-4EF4-A6D6-E57A7934FE2BQ28469216-E65CB3C4-0B4E-434B-B53B-303344B3A1C4Q28487924-DAF59A84-5BE5-4AB2-BC61-F8B7D1C3A5BAQ33381199-6B1C727E-1F5A-40B8-BA20-60401E041331Q33921024-88A49C62-C95B-41D5-AF79-77AE0197B8E9Q34111215-805EF9F4-ECAE-4AFE-8641-E3F069C731CEQ34783706-E7E6ECBF-3267-45EB-9440-D3AADC25912DQ34826154-2B35B225-F913-4FEB-8A6F-7419DC87DED1Q35008501-B51CE8EA-90E3-4313-B6FA-68403945BA3BQ35010568-A3A713A6-213D-41BB-8FC0-FC25CC85FC1DQ35092318-FEE739BA-DDDC-452B-9AA4-2B7FB1558956Q35742655-4A6A0E38-72B1-4A16-A486-7B5A3267A91EQ35987440-7652AF92-CDE1-4154-8971-CF9A42E45249Q36241242-8C3B559B-6B65-495F-8070-B45631F2B554Q36936267-99F06938-E8B0-4A17-9762-223F3B2E1491Q36947173-2A789F70-0D31-4780-937B-CB85075E59EEQ37021662-E2121F1B-5435-4009-A716-8DC0121DBF0AQ37126542-3719B12C-9EE7-4D7B-A6E3-2F670F76886BQ37481355-6057BFD9-382C-4CC8-BFD8-9FD81CF4899CQ37862392-ADAD5DBC-10F5-45CB-90E4-910F5B553FAEQ37868056-C9421EDE-18E3-423B-BDE6-80CE65DCA9CFQ37887817-22A1E2AA-6322-4A88-AB10-B9D96C957C72Q37902641-708074B4-A35E-4170-B597-1A60354454D7Q37913983-33763146-E376-4865-8BA8-0239067363A5Q37950948-DF1C4D18-F51B-4712-93F7-076F170BDE0EQ37988590-222C4263-FB04-4173-A0EF-94A1F3D25FC3Q37989075-CF852CF3-464F-48F2-9B4F-5348DA67D4F7Q38019954-EC328701-68E0-4C7D-B9CD-64EBA798EF5AQ38076273-D9BBE3FB-31EF-4B4F-85C2-B353897E94EBQ38077764-F14E8582-1364-4F03-8E9F-0B7E5763075BQ38639852-247C8499-A1EC-40DF-9E32-BD7C7630F30CQ38861952-FF12B9A3-4D04-409C-9D85-75ACA49C1FF3Q39330552-9C283DCD-3F08-4D2C-B81F-736840EDC5DDQ39728931-639D34ED-E035-4176-9977-3D154621F4CCQ41811019-03AE2937-C109-4834-9969-89FF5ED60801Q43702348-D56CF459-DA7C-45DB-A42C-F106CD4123C7Q47139353-D9CD3DA5-F4FE-46FA-95F2-30BC71954311Q47203358-A86E07E1-B93E-4D1C-9570-8AC6CC793534Q48731543-F6A50F65-918C-4E6C-8AEF-3953B109E472
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Update on tubulin-binding agents.
@ast
Update on tubulin-binding agents.
@en
Update on tubulin-binding agents.
@nl
type
label
Update on tubulin-binding agents.
@ast
Update on tubulin-binding agents.
@en
Update on tubulin-binding agents.
@nl
prefLabel
Update on tubulin-binding agents.
@ast
Update on tubulin-binding agents.
@en
Update on tubulin-binding agents.
@nl
P1476
Update on tubulin-binding agents
@en
P2093
Johann De Bono
P356
10.1016/J.PATBIO.2005.03.003
P577
2006-03-01T00:00:00Z